HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Volumn 35, Issue 4, 2017, Pages 446-464

  Bartley, Angela N ^a   Washington, Mary Kay ^a   Colasacco, Carol ^a   Ventura, Christina B ^a   Ismaila, Nofisat ^a   Benson, Al B ^a   Carrato, Alfredo ^a   Gulley, Margaret L ^a   Jain, Dhanpat ^a   Kakar, Sanjay ^a   Mackay, Helen J ^a   Streutker, Catherine ^a   Tang, Laura ^a   Troxell, Megan ^a   Ajani, Jaffer A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ALGORITHM; ENZYMOLOGY; ESOPHAGUS TUMOR; GASTROESOPHAGEAL JUNCTION; HUMAN; PATHOLOGY; PRACTICE GUIDELINE; STOMACH TUMOR;

ADENOCARCINOMA; ALGORITHMS; BIOMARKERS, TUMOR; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; RECEPTOR, ERBB-2; STOMACH NEOPLASMS;

EID: 85020682540     PISSN: None     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.69.4836     Document Type: Article

References (0)